Common side-effects of BTK inhibitors (ibrutinib and acalabrutinib) in the treatment of CLL
How to reduce anxiety levels in patients undergoing bone marrow biopsy
Evolutionary biology and CLL therapy
Overcoming the challenges of evolving standards of care in CLL: advice for community physicians
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?